Reva Medical, Inc. (RVALL) SEC Filing 8-K Material Event for the period ending Tuesday, March 5, 2019

Reva Medical, Inc.

CIK: 1496268 Ticker: RVALL

View differences made from one to another to evaluate Reva Medical, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Reva Medical, Inc..


Assess how Reva Medical, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Reva Medical, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Reva Medical, Inc. provided additional information to their SEC Filing as exhibits

Ticker: RVALL
CIK: 1496268
Form Type: 8-K Corporate News
Accession Number: 0001564590-19-006333
Submitted to the SEC: Tue Mar 05 2019 6:13:43 PM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Tuesday, March 5, 2019
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: